StocksMedium•5 November 2026•
1 min read
Precision BioSciences Prices $125 Million Public Offering
Key Facts
1Precision BioSciences announced the pricing of an underwritten offering of common stock and pre-funded warrants for total gross proceeds of $125 million.
2The offering price was set at $7.75 per share, involving over 10 million shares of common stock.
Precision BioSciences announced the pricing of an underwritten public offering of common stock and pre-funded warrants for total gross proceeds of $125 million. Business Wire reported that the offering price was set at $7.75 per share, involving more than 10 million shares of common stock.
The capital raise is intended to fund the company's ARCUS gene editing platform and general corporate purposes. DTIL closed at $8.12 on November 4, 2026, having reached a day high of $8.13 and a day low of $7.14 during that session.